| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8459402 | Radiotherapy and Oncology | 2017 | 7 Pages | 
Abstract
												TRT added to ChT improved ES-SCLC patient OS. High dose TRT improved OS over lower doses. Our results suggest that high-dose thoracic radiation therapy may be a reasonable consideration in select patients with ES-SCLC.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Cancer Research
												
											Authors
												Li-Ming Xu, Lu-jun Zhao, Charles B. II, Chingyun Cheng, Minglei Kang, Xin Wang, Lin-Lin Gong, Qing-Song Pang, Jun Wang, Zhi-yong Yuan, Ping Wang, 
											